BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17369522)

  • 1. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
    Ingelsson E; Sullivan LM; Murabito JM; Fox CS; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Diabetes; 2007 Jun; 56(6):1718-26. PubMed ID: 17369522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.
    Ingelsson E; Sullivan LM; Fox CS; Murabito JM; Benjamin EJ; Polak JF; Meigs JB; Keyes MJ; O'Donnell CJ; Wang TJ; D'Agostino RB; Wolf PA; Vasan RS
    Circulation; 2007 Jul; 116(4):375-84. PubMed ID: 17620505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
    Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
    Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
    Stern MP; Williams K; Hunt KJ
    Atheroscler Suppl; 2005 May; 6(2):3-6. PubMed ID: 15823490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
    Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
    Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between ankle-brachial index and cardiovascular or all-cause mortality in metabolic syndrome of elderly Chinese.
    Xu Y; Li J; Luo Y; Wu Y; Zheng L; Yu J; Ma J; Gu J; Hu D
    Hypertens Res; 2007 Jul; 30(7):613-9. PubMed ID: 17785929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
    Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
    Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population.
    Andreadis EA; Tsourous GI; Tzavara CK; Georgiopoulos DX; Katsanou PM; Marakomichelakis GE; Diamantopoulos EJ
    Am J Hypertens; 2007 May; 20(5):558-64. PubMed ID: 17485022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
    Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
    Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores.
    Mora S; Redberg RF; Sharrett AR; Blumenthal RS
    Circulation; 2005 Sep; 112(11):1566-72. PubMed ID: 16144993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
    Ingelsson E; Pencina MJ; Tofler GH; Benjamin EJ; Lanier KJ; Jacques PF; Fox CS; Meigs JB; Levy D; Larson MG; Selhub J; D'Agostino RB; Wang TJ; Vasan RS
    Circulation; 2007 Aug; 116(9):984-92. PubMed ID: 17698726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.